CTT Pharmaceutical Holdings, Inc. has filed a Current Report on Form 8-K dated October 8, 2026, to address a matter regarding its previous disclosures. The company stated that it is filing a response from the auditor of its last 8-K filing. The filing confirms that the auditor has agreed with the disclosures previously made by CTT Pharma.
The registrant is listed as CTT Pharmaceutical Holdings, Inc., with its principal executive offices located at 1646 W Snow Ave, Suite 138, Tampa, FL 33606. The company's telephone number is 813-606-0060. The filing was signed on October 9, 2026, by Ryan Khouri, who serves as the Chief Executive Officer and Principal Executive, Financial and Accounting Officer.
Item 4.01 of the report pertains to Changes in Registrant’s Certifying Accountant. The company notes that the auditor has affirmed the content of the prior filing. Additionally, Item 9.01 includes Financial Statements and Exhibits, specifically referencing Exhibit 16.1, which consists of a Letter.
